Interaction of neurodevelopmental pathways and synaptic plasticity in mental retardation, autism spectrum disorder and schizophrenia: Implications for psychiatry

World Journal of Biological Psychiatry

Volumn 15, Issue 7, 2014, Pages 507-516

  Waltereit, Robert ^a,b   Banaschewski, Tobias ^a   Meyer Lindenberg, Andreas ^a   Poustka, Luise ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Autism spectrum disorder; Developmental psychopathology; Genetics; Mental retardation; Schizophrenia

Indexed keywords

AUTISM; DSM-IV; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; HUMAN; ICD-10; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROPSYCHIATRY; PHENOTYPE; REVIEW; SCHIZOPHRENIA; SOCIAL COGNITION; INTELLECTUAL IMPAIRMENT;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; INTELLECTUAL DISABILITY; NEURONAL PLASTICITY; SCHIZOPHRENIA;

EID: 84907278366     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.838641     Document Type: Review

References (89)

1. Addington AM, Rapoport JL. 2012. Annual research review: Impact of advances in genetics in understanding developmental psychopathology. J Child Psychol Psychiatry 53: 510-518.
2. Andreasen NC, Olsen S. 1982. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39: 789-794.
3. Arguello PA, Gogos JA. 2012. Genetic and cognitive windows into circuit mechanisms of psychiatric disease. Trends Neurosci 35: 3-13.
4. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, et al. 2008. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82: 160-164.
5. Asperger H. 1944. Die Autistischen Psychopathen im Kindesalter . Arch Psychiatr Nervenkr 117: 76-136.
6. Bagni C, Greenough WT. 2005. From mRNP trafficking to spine dysmorphogenesis: The roots of fragile X syndrome. Nat Rev Neurosci 6: 376-387.
7. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, et al. 2006. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: The Special Needs and Autism Project (SNAP). Lancet 368: 210-215.
8. Baron-Cohen S, Belmonte MK. 2005. Autism: A window onto the development of the social and the analytic brain. Annu Rev Neurosci 28: 109-126.
9. Beri S, Tonna N, Menozzi G, Bonaglia MC, Sala C, Giorda R. 2007. DNA methylation regulates tissue-specifi c expression of Shank3. J Neurochem 101: 1380-1391.
10. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, et al. 2000. Neuropsychology of fi rst-episode schizophrenia: Initial characterization and clinical correlates. Am J Psychiatry 157: 549-559.
11. Bockers TM, Segger-Junius M, Iglauer P, Bockmann J, Gundelfinger ED, Kreutz MR, et al. 2004. Differential expression and dendritic transcript localization of Shank family members: Identifi cation of a dendritic targeting element in the 3 ? untranslated region of Shank1 mRNA. Mol Cell Neurosci 26: 182-190.
12. Bonora E, Lamb JA, Barnby G, Bailey AJ, Monaco AP. 2006. Genetic basis of autism. In: Moldin SO, Rubenstein JLR, editors. Understanding autism: From basic neuroscience to treatment . Boca Raton, FL: CRC Press. p. 49-74.
13. Bora E, Yucel M, Pantelis C. 2009. Theory of mind impairment in schizophrenia: Meta-Analysis. Schizophr Res 109: 1-9.
14. Brandon NJ, Millar JK, Korth C, Sive H, Singh KK, Sawa A. 2009. Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci 29: 12768-12775.
15. Chakrabarti S, Fombonne E. 2005. Pervasive developmental disorders in preschool children: Confi rmation of high prevalence. Am J Psychiatry 162: 1133-1141.
16. Chao HT, Zoghbi HY, Rosenmund C. 2007. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56: 58-65.
17. Charman T, Pickles A, Simonoff E, Chandler S, Loucas T, Baird G. 2011. IQ in children with autism spectrum disorders: Data from the Special Needs and Autism Project (SNAP). Psychol Med 41: 619-627.
18. Ching MS, Shen Y, Tan WH, Jeste SS, Morrow EM, Chen X, et al. 2010. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 153B: 937-947.
19. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, et al. 2009. Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166: 540-556.
20. Cohen E, Chow E, Weksberg R, Bassett AS. 1999. Phenotype of adults with the 22q11 deletion syndrome: A review. Am J Med Genet 86: 359-365.
21. Consortium IS. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237-241.
22. Cook EH, Jr, Scherer SW. 2008. Copy-number variations associated with neuropsychiatric conditions. Nature 455: 919-923.
23. Crespi B, Stead P, Elliot M. 2010. Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 107(Suppl.): 1736-1741.
24. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M, et al. 2008. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 121: E1357-62.
25. Dasgupta B, Gutmann DH. 2003. Neurofi bromatosis 1: Closing the GAP between mice and men. Curr Opin Genet Dev 13: 20-27.
26. Devlin B, Daniels M, Roeder K. 1997. The heritability of IQ. Nature 388: 468-471.
27. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al. 2008. Reversal of learning Deficits in a Tsc2-/-mouse model of tuberous sclerosis. Nat Med 14: 843-848.
28. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, Van der Vliet WA, Faas BH, et al. 2008. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13: 261-266.
29. Gottesman II. 1971. An introduction to behavioral genetics of mental retardation. In: Allen RM, editor. Role of Genetics in Mental Retardation. University of Miami, FL: Coral Gables. p. 49-69.
30. Grabrucker AM, Knight MJ, Proepper C, Bockmann J, Joubert M, Rowan M, et al. 2011. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J 30: 569-581.
31. Greenwood CM, Husted J, Bomba MD, Hodgkinson KA, Bassett AS. 2004. Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res 48: 531-539.
32. Groffen AJ, Friedrich R, Brian EC, Ashery U, Verhage M. 2006. DOC2A and DOC2B are sensors for neuronal activity with unique calcium-dependent and kinetic properties. J Neurochem 97: 818-833.
33. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66: 947-956.
34. Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, et al. 2007. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry 164: 813-819.
35. Howard MA, Elias GM, Elias LA, Swat W, Nicoll RA. 2010. The role of SAP97 in synaptic glutamate receptor dynamics. Proc Natl Acad Sci USA 107: 3805-3810.
36. Johns LC, Van Os J. 2001. The continuity of psychotic experiences in the general population. Clin Psychol Rev 21: 1125-1141.
37. Jones P, Rodgers B, Murray R, Marmot M. 1994. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344: 1398-1402.
38. Kanner L. 1943. Autistic disturbances of affective contact. Nerv Child 2: 217-250.
39. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, et al. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 92: 7612-7616.
40. Karayiorgou M, Simon TJ, Gogos JA. 2010. 22q11.2 microdeletions: Linking DNA structural variation to brain dysfunction and schizophrenia. Nature reviews. Neuroscience 11: 402-416.
41. Kaski M. 2000. Aetiology of mental retardation: General issues and prevention. In: Gelder MG, Lopez-Ibor JJ, Andreasen N, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press.
42. Kelleher RJ 3rd, Bear MF. 2008. The autistic neuron: Troubled translation? Cell 135: 401-406.
43. Kendler KS, Diehl SR. 1995. Schizophrenia: Genetics. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 6th ed. Baltimore, ND: Williams & Wilkins. p 942-957.
44. Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. 2008. Psychopathology among offspring of parents with schizophrenia: Relationship to premorbid impairments. Schizophr Res 103: 114-120.
45. Kirov G, Rujescu D, Ingason A, Collier DA, ODonovan MC, Owen MJ. 2009. Neurexin 1 (NRXN1) deletions in schizophrenia . Schizophr Bull 35: 851-854.
46. Kolvin I. 1971. Studies in the childhood psychoses: I. Diagnostic criteria and classifi cation. Br J Psychiatry 118: 381-384.
47. Konstantareas MM, Hewitt T. 2001. Autistic disorder and schizophrenia: Diagnostic overlaps. J Autism Dev Disord 31: 19-28.
48. Kraepelin E. 1919. Dementia praecox and paraphrenia. Chicago: Chicago Medical Book.
49. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. 2005. Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 161: 916-918.
50. Lederbogen F, Kirsch P, Haddad L, Streit F, Tost H, Schuch P, et al. 2011. City living and urban upbringing affect neural social stress processing in humans. Nature 474: 498-501.
51. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. 2009. Finding the missing heritability of complex diseases. Nature 461: 747-753.
52. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. 2008. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488.
53. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, DSouza C, Fouse SD, et al. 2010. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257.
54. Meyer-Lindenberg A, Bullmore ET. 2011. Functional brain imaging in schizophrenia. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. 3rd ed. Chichester: Wiley-Blackwell. p. 353-371.
55. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. 2011. Oxytocin and vasopressin in the human brain: Social neuropeptides for translational medicine. Nat Rev Neurosci 12: 524-538.
56. Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, et al. 2012. Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11: 141-168.
57. Minshew NJ, Webb SJ, Williams DL, Dawson G. 2006. Neuropsychology and neurophysiology of autism spectrum disorders. In: Moldin SO, Rubenstein JLR, editors. Understanding autism: From basic neuroscience to treatment. Boca Raton, FL: CRC Press. p. 379-416.
58. Mitchell KJ. 2010. The genetics of neurodevelopmental disease. Curr Opin Neurobiol 21: 1-7.
59. Morris RW, Weickert CS, Loughland CM. 2009. Emotional face processing in schizophrenia. Curr Opin Psychiatry 22: 140-146.
60. Morrow EM. 2010. Genomic copy number variation in disorders of cognitive development. J Am Acad Child Adolesc Psychiatry 49: 1091-1104.
61. Murphy K, Jones L, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56: 940-945.
62. Nakagawa T, Futai K, Lashuel HA, Lo I, Okamoto K, Walz T, et al. 2004. Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions . Neuron 44: 453-467.
63. Nakajima Y, Okamoto M, Nishimura H, Obata K, Kitano H, Sugita M, et al. 2001. Neuronal expression of mint1 and mint2, novel multimodular proteins, in adult murine brain. Brain Res Mol Brain Res 92: 27-42.
64. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, et al. 2009. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5: E1000373.
65. Niemi LT, Suvisaari JM, Haukka JK, Lonnqvist JK. 2005. Childhood predictors of future psychiatric morbidity in offspring of mothers with psychotic disorder: Results from the Helsinki High-Risk Study. Br J Psychiatry 186: 108-114.
66. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al. 2011. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472: 437-442.
67. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. 2010. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466: 368-372.
68. Piton A, Gauthier J, Hamdan FF, Lafreniere RG, Yang Y, Henrion E, et al. 2011. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia . Mol Psychiatry 16: 867-880.
69. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, et al. 1999. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K-channels. Neuron 24: 1037-1047.
70. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. 2009. Autism spectrum disorders and childhoodonset schizophrenia: Clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 48: 10-18.
71. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM, et al. 2010. Static and dynamic cognitive Deficits in childhood preceding adult schizophrenia: A 30-year study. Am J Psychiatry 167: 160-169.
72. Rosanoff AJ, Handy LM, Plesset IR. 1937. The etiology of mental Deficiency with special reference to its occurrence in twins. Psychol Monogr 216: 1-137.
73. Rutter M. 1972. Childhood schizophrenia reconsidered. J Autism Child Schizophr 2: 315-337.
74. Schneider K. 1959. Clinical psychopathology. New York: Grune and Stratton.
75. Schutt J, Falley K, Richter D, Kreienkamp HJ, Kindler S. 2009. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J Biol Chem 284: 25479-25487.
76. Sebat J, Levy DL, McCarthy SE. 2009. Rare structural variants in schizophrenia: One disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 25: 528-535.
77. Skokauskas N, Gallagher L. 2010. Psychosis, affective disorders and anxiety in autistic spectrum disorder: Prevalence and nosological considerations. Psychopathology 43: 8-16.
78. Sweatt JD. 2003. Mechanisms of memory. San Diego, CA: Academic Press.
79. Swistowski A, Zhang Q, Orcholski ME, Crippen D, Vitelli C, Kurakin A, et al. 2009. Novel mediators of amyloid precursor protein signaling. J Neurosci 29: 15703-15712.
80. Tonge BJ. 2000. Psychiatric and behaviour disorders among mentally retarded children and adolescents. In: Gelder MG, Lopez-Ibor JJ, Andreasen N, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press. p. 1965-1972.
81. Turner TH. 1989. Schizophrenia and mental handicap: An historical review, with implications for further research. Psychol Med 19: 301-314.
82. Volkmar FR, Klin A. 2000. Autism and pervasive developmental disorders. In: Gelder MG, Lopez-Ibor JJ, Andreasen N, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press. p 1723-1734.
83. Vorstman J, Morcus M, Duijff S, Klaassen P, Heineman-de Boer J, Beemer F, et al. 2006. The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45: 1104-1113.
84. De Vries PJ, Howe CJ. 2007. The tuberous sclerosis complex proteins-A GRIPP on cognition and neurodevelopment. Trends Mol Med 13: 319-326.
85. Walsh CA, Engle EC. 2010. Allelic diversity in human developmental neurogenetics: Insights into biology and disease. Neuron 68: 245-253.
86. Walsh CA, Morrow EM, Rubenstein JL. 2008. Autism and brain development. Cell 135: 396-400.
87. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
88. Waltereit R, Welzl H, Dichgans J, Lipp HP, Schmidt WJ, Weller M. 2006. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis. J Neurochem 96: 407-413.
89. Zweier C, De Jong EK, Zweier M, Orrico A, Ousager LB, Collins AL, et al. 2009. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 85: 655-666.